Literature DB >> 24706143

Are there sufficient standards for the in vitro hemocompatibility testing of biomaterials?

Steffen Braune1, Michael Grunze, Andreas Straub, Friedrich Jung.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 24706143     DOI： 10.1186/1559-4106-8-33

Source DB:  PubMed          Journal:  Biointerphases        ISSN： 1559-4106            Impact factor:   2.456


× No keyword cloud information.
  6 in total

Review 1.  Blood-Contacting Biomaterials: In Vitro Evaluation of the Hemocompatibility.

Authors:  Marbod Weber; Heidrun Steinle; Sonia Golombek; Ludmilla Hann; Christian Schlensak; Hans P Wendel; Meltem Avci-Adali
Journal:  Front Bioeng Biotechnol       Date:  2018-07-16

2.  The optimal incubation time for in vitro hemocompatibility testing: Assessment using polymer reference materials under pulsatile flow with physiological wall shear stress conditions.

Authors:  Sjoerd Leendert Johannes Blok; Willem van Oeveren; Gerwin Erik Engels
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2019-01-29       Impact factor: 3.368

Review 3.  Predicting the In Vivo Performance of Cardiovascular Biomaterials: Current Approaches In Vitro Evaluation of Blood-Biomaterial Interactions.

Authors:  Anne Strohbach; Raila Busch
Journal:  Int J Mol Sci       Date:  2021-10-21       Impact factor: 5.923

4.  The Role of Biodegradable Poly-(L-lactide)-Based Polymers in Blood Cell Activation and Platelet-Monocyte Interaction.

Authors:  Anne Strohbach; Friedemann Maess; Katharina Wulf; Svea Petersen; Niels Grabow; Klaus-Peter Schmitz; Stephan B Felix; Raila Busch
Journal:  Int J Mol Sci       Date:  2021-06-13       Impact factor: 5.923

5.  Hemocompatibility of styrenic block copolymers for use in prosthetic heart valves.

Authors:  Jacob Brubert; Stefanie Krajewski; Hans Peter Wendel; Sukumaran Nair; Joanna Stasiak; Geoff D Moggridge
Journal:  J Mater Sci Mater Med       Date:  2015-12-24       Impact factor: 3.896

6.  In vitro methodology for medical device material thrombogenicity assessments: A use condition and bioanalytical proof-of-concept approach.

Authors:  Michael F Wolf; Gaurav Girdhar; Arielle A Anderson; Samantha R Ubl; Sinduja Thinamany; Hannah N Jeffers; Courtney E DeRusha; Jenny Rodriguez-Fernandez; Sebastian Hoffmann; Carrie A Strief
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2020-09-14       Impact factor: 3.368
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.